Imipramine distribution among red blood cells, plasma and brain tissue

General Physiology and Biophysics

Volumn 15, Issue 1, 1996, Pages 51-64

  Fisar Z ^a   Krulik R ^a   Fuksova K ^a   Sikora, J ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

blood; brain; imipramine; membrane

Indexed keywords

IMIPRAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN HOMOGENATE; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLASMA; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BRAIN; CYTOSOL; DESIPRAMINE; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; IMIPRAMINE; MEMBRANES; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; TISSUE DISTRIBUTION; TRITIUM;

ANIMALIA;

EID: 0029930831     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Ackenheil M. (1990): The mechanism of action of antidepressants revised. J. Neural Transmission Suppl. 32, 29-37
2. Åsberg M., Sjöqvist F. (1978): On the role of plasma level monitoring of tricyclic antidepressants in clinical practice. Commun. Psychopharmacol. 2, 381-391
3. Aymard N., Renouard C., Leyris A., Carbuccia I. (1993): Significance of determining erythrocyte levels of tricyclic antidepressants, tetracyclic antidepressants and their demethylated derivatives. In: Biologie Prospective: Comptes Rendus du 8 Colloque de Pont-a-Mousson (Eds. M. M. Galteau, G. Siest, J. Henny, D. Bagrel and B. Beaud) pp. 191-194, John Libbey Eurotext, Paris
4. Bartlett G. R. (1959): Phosphorus assay in column chromatography. J. Biol. Chem. 234, 466-468
5. Bauer M., Megret C., Lamure A., Lacabanne C., Fauran-Clavel M.-J. (1990): Differential scanning calorimetry study of the interaction of antidepressant drugs, noradrenaline and 5-hydroxytryptamine with a membrane model. J. Pharm. Sci. 79, 897-901
6. Bhat G. B., Block E. R. (1992): Serotonin transport in reconstituted endothelial cell plasma membrane proteoliposomes: effect of hypoxia. Amer. J. Respir. Cell Molec. Biol. 6, 633-638
7. Bickel R. P. (1975): Binding of chlorpromazine and imipramine to red cells, albumin, lipoproteins and other blood components. J. Pharm. Pharmacol. 27, 733-738
8. Caldecott-Hazard S., Morgan D. G., DeLeon-Jones F., Overstreet D. H., Janowsky D. (1991): Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories. Synapse 9, 251-301
9. Daniel W., Adamus A., Melzacka M., Szymura J., Vetulani J. (1981): Cerebral pharmacokinetics of imipramine in rats after single and multiple dosages. Naunyn-Schmied. Arch. Pharmacol. 317, 209-213
10. Daniel W., Adamus A., Melzacka M., Szymura J. (1982): The route of administration of imipramine as a factor affecting formation of its metabolite desipramine. J. Pharm. Pharmacol. 34, 678-680
11. Fišar Z., Krulík R., Beitlová D. (1991): Liposomes - model membranes to study the binding of tricyclic antidepressants. Drug Metabol. Drug Interac. 9, 269-281
12. Friedman E., Cooper T. B. (1983): Pharmacokinetics of chlorimipramine and its demethylated metabolite in blood and brain regions of rats treated acutely and chronically with chlorimipramine. J. Pharmacol. Exp. Ther. 225, 387-390
13. Glassman A. H. (1994): Antidepressant plasma levels revisited. Int. Clin. Psychopharmacol. 9, Suppl. 2, 25-30
14. Graham D., Langer S. Z. (1992): Advances in sodium-ion coupled biogenic amine transporters. Life Sci. 51, 631-645
15. Heirwegh K. P. M., De Smedt H., Vermeir M. (1992): Analysis of membrane-bound acceptors. A correction function for non-specific accumulation of poorly water-soluble hydrophobic or amphipatic ligands based on the ligand partition concept. Biochem. Pharmacol. 43, 701-704
16. Hudson C. J., Young L. T., Li P. P., Warsh J. J. (1993): CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Synapse 13, 278-293
17. Javaid J. I., Davis J. M., Maiorano M. (1985): Uptake and/or binding of tricyclic antidepressants in human red cells. Life Sci. 36, 1761-1769
18. Krulík R., Exner J., Fuksová K., Píchová D., Beitlová D., Sikora J. (1991a): Radioimmunoassay of dibenzazepines and dibenzcycloheptanodienes in body fluids and tissues. Eur. J. Clin. Chem. Clin. Biochem. 29, 827-832
19. Krulík R., Sikora J., Bureš P., Fuksová K. (1991b): Methylated and demethylated tricyclic antidepressants and their binding to cell membranes. Drug Metab. Drug Interact. 9, 283-291
20. Linnoila M., Dorrity F., Jobson K. (1978): Plasma and erythrocyte levels of tricyclic antidepressants in depressed patients. Amer. J. Psychiat. 135, 557-561
21. Manji H. K. (1992): G proteins: implications for psychiatry. Amer. J. Psychiat. 149, 746-760
22. Marcusson J. O., Ross S. B. (1990): Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets. Psychopharmacology 102, 145-155
23. Masada M., Suzuki K., Kituta S., Yamashita S., Nakanishi K., Nadai T., Igarashi Y. (1986): Regional distribution and elimination kinetics of imipramine in rat brain after multiple dosages. Chem. Pharm. Bull. (Tokyo) 34, 927-930
24. Mason R. P., Rhodes D. G., Herbette L. G. (1991): Reevaluating equilibrium and kinetic binding parameters for lipophilic drugs based on structural model for drug interaction with biological membranes. J. Med. Chem. 34, 869-877
25. Matuzas W., Javaid J. I., Uhlenhuth E. H., Davis J. M., Glass R. M. (1983): Plasma and red blood cell imipramine levels and clinical response among depressed outpatients. Psychopharmacol. Bull. 19, 652-655
26. Miyake K., Fukuchi H., Kitaura T., Kimura M., Sarai K., Nakahara T. (1990): Pharmacokinetics of amitriptyline and its demethylated metabolite in serum and specific brain regions of rats after acute and chronic administration of amitriptyline. J. Pharm. Sci. 79, 288-291
27. Moor M., Honegger U. E., Wiesmann U. N. (1988): Organspecific, qualitative changes in the phospholipid composition of rats after chronic administration of the antidepressant drug desipramine. Biochem. Pharmacol. 37, 2035-2039
28. Musa M. N. (1979): Imipramine plasma level differences in depression types. Res. Commun. Psychol. Psychiat. Behav. 4, 109-114
29. Musa M. N. (1981): Depression sub-types affect the steady-state plasma levels and therapeutic efficacy of amitriptyline and nortriptyline. Res. Commun. Psychol. Psychiat. Behav. 6, 1-8
30. Nagy A. (1977): Blood and brain concentrations of imipramine, clomipramine and their monomethylated metabolites after oral and intramuscular administration in rats. J. Pharm. Pharmacol. 29, 104-107
31. Perel J. M., Stiller R. L., Glassman A. H. (1978): Studies on plasma level/effect relationships in imipramine therapy. Commun. Psychopharmacology 2, 429-439
32. Perry P. J., Zeilmann C., Arndt S. (1994): Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response. J. Clin. Psychopharmacol. 14, 230-240
33. Risch S. C., Huey L. Y., Janowsky D. S. (1979): Plasma levels of tricyclic antidepressants and clinical efficacy: review of the literature - Part I. J. Clin. Psychiatry 40, 9-21
34. Ruben Z., Rorig K. J., Kacew S. (1993): Perspectives on intracellular storage and transport of cationic-lipophilic drugs. Proc. Soc. Exp. Biol. Med. 203, 140-149
35. Seydel J. K., Coats E. A., Cordes H. P., Wiese M. (1994): Drug membrane interaction and the importance for drug transport, distribution, accumulation, efficacy and resistance. Arch. Pharm. 327, 601-610
36. Sikora J., Krulík R., Beitlová D., Příhoda P. (1990): Plasma levels of antidepressants after their withdrawal. Endocrin. Exp. 24, 221-227
37. Toplak H., Zuehlke R., Loidl S., Hermetter A., Honegger U. E., Wiesmann U. N. (1990): Single and multiple desipramine exposures of cultured cells. Changes in cellular anisotropy and in lipid composition of whole cells and of plasma membranes. Biochem. Pharmacol. 39, 1437-1443
38. Wachtel H. (1990): The second-messenger dysbalance hypothesis of affective disorders. Pharmacopsychiatry 23, 27-32
39. o-type GTP binding protein by tricyclic antidepressants. Neurosci. Lett. 139, 194-196